Cargando…
Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma
Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant clonal plasma cell disorder, with a 1% yearly risk of progression to multiple myeloma (MM). Evolution of M‐spike and serum free light chain (sFLC) during follow‐up could identify patients at high risk of progression. In this...
Autores principales: | Gran, Charlotte, Liwing, Johan, Wagner, Arnika Kathleen, Verhoek, Andre, Gezin, Ana, Alici, Evren, Nahi, Hareth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756706/ https://www.ncbi.nlm.nih.gov/pubmed/32936979 http://dx.doi.org/10.1002/ajh.25999 |
Ejemplares similares
-
Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma
por: Nahi, Hareth, et al.
Publicado: (2019) -
Gamma-heavy chain monoclonal gammopathy with undetermined significance (MGUS)
por: Zushi, Yuriko, et al.
Publicado: (2019) -
Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance()
por: Shimanovsky, Alexei, et al.
Publicado: (2016) -
Dynamic follow‐up of smoldering multiple myeloma identifies a subset of patients at high risk of progression
por: Gran, Charlotte, et al.
Publicado: (2020) -
Immunophenotypic studies of monoclonal gammopathy of undetermined significance
por: Olteanu, Horatiu, et al.
Publicado: (2008)